Yahoo
Jakarta - Delayed Quote IDR

PT Prodia Widyahusada Tbk (PRDA.JK)

3,680.00 +50.00 (+1.38%)
At close: 4:11:35 PM GMT+7
Chart Range Bar
Loading chart for PRDA.JK
  • Previous Close 3,630.00
  • Open 3,630.00
  • Bid 3,660.00 x --
  • Ask 3,680.00 x --
  • Day's Range 3,620.00 - 3,700.00
  • 52 Week Range 2,230.00 - 3,760.00
  • Volume 1,458,300
  • Avg. Volume 1,166,809
  • Market Cap (intraday) 3.274T
  • Beta (5Y Monthly) 0.03
  • PE Ratio (TTM) 15.16
  • EPS (TTM) 242.81
  • Earnings Date --
  • Forward Dividend & Yield 162.68 (4.52%)
  • Ex-Dividend Date May 5, 2026
  • 1y Target Est 3,950.00

PT Prodia Widyahusada Tbk provides clinical laboratory services in Indonesia. The company offers test services, such as genomic, laboratory, and non-laboratory tests, as well as test panels; doctor consultation and teleconsultation services; vaccines; home services; and research support services. It also engages in the operation of Prodia Health Care, a personalized medicine-based wellness clinic; and specialty clinics, including Prodia Children, Prodia Women, and Prodia Senior. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk operates as a subsidiary of PT Prodia Utama.

prodia.co.id/id

2,908

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

PRDA.JK
70.68%
IDX COMPOSITE (^JKSE)
43.28%

1-Year Return

PRDA.JK
52.75%
IDX COMPOSITE (^JKSE)
40.73%

3-Year Return

PRDA.JK
27.32%
IDX COMPOSITE (^JKSE)
27.76%

5-Year Return

PRDA.JK
31.97%
IDX COMPOSITE (^JKSE)
25.15%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY19
Revenue --
Earnings 33.73B
Profit Margin 0.00%

Q1

FY19

Q2

FY19

0
100B
200B
300B
0.0%

Analyst Insights

View More

Analyst Price Targets

3,950.00
3,950.00 Average
3,680.00 Current
3,950.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.06%

  • Return on Assets (ttm)

    5.93%

  • Return on Equity (ttm)

    9.22%

  • Revenue (ttm)

    2.37T

  • Net Income Avi to Common (ttm)

    214.69B

  • Diluted EPS (ttm)

    242.81

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    688.99B

  • Total Debt/Equity (mrq)

    0.90%

  • Levered Free Cash Flow (ttm)

    254.61B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: